Introduction
Most anticancer modalities kill cancer cells through 'physiological' apoptosis, 1, 2 which in immunological terms is tolerogenic in nature. [2] [3] [4] [5] However, it has recently emerged that certain modalities can kill the cancer cells through an apoptotic cell death subroutine that is actively immunostimulatory, termed as immunogenic apoptosis or cell death. [6] [7] [8] Cancer cells undergoing immunogenic cell death have the ability to stimulate and activate the innate immune cells like dendritic cells, which in turn "cross-prime" the adaptive immune system for the antigens of the dying cancer cells, thereby leading to effective activation of antitumor immunity. [6] [7] [8] [9] In molecular terms ICD is characterized by the rapid (1 to 4 h post-treatment) surface exposure of calreticulin, 7, 9, 10 early secretion of ATP 9, [11] [12] [13] (both in the absence of plasma membrane permeabilization) as well as late apoptotic (passive) release of proteins (i.e., following plasma membrane permeabilization) like heat shock proteins (HSPs) 9, 14 and high mobility group box 1; 15 all of which are potent immunogenic signals. 2, [16] [17] [18] In immunological terms ICD is characterized by increased maturation or stimulation of DCs accompanied by IL1B production, which is required for the subsequent stimulation and proliferation of antitumorigenic, IFNG-producing, CD4 + or CD8 + T cells; 11, 13 all of which together are indispensible for ICD's ability to induce potent antitumor immunity. 2, 19 We recently characterized that hypericin-based photodynamic therapy [19] [20] [21] causes induction of bona fide immunogenic cancer cell death. 9, 10, 17 Hypericin is an endoplasmic reticulum-associated photosensitiser, 14 which when activated by light, evokes the production of reactive oxygen species, photooxidative (phox) stress-mediated loss-of-function of ATP2A2 (ATPase, Ca++ transporting, cardiac muscle, slow twitch 2, also called sarcoplasmic/endoplasmic reticulum calcium ATPase 2), disruption of ER-Ca 2+ homeostasis and induction of phox-ER stress. 9, 22, 23 Phox-ER stress is characterized by the activation of the EIF2AK3-EIF2A-ATF4 branch (EIF2AK3: eukaryotic translation initiation factor 2-alpha kinase 3, also called PKR-like ER kinase; EIF2A: eukaryotic translation initiation factor 2A; and ATF4: activating transcription factor 4) and ERN1-XBP1 branch (ERN1: endoplasmic reticulum to nucleus signaling 1, also called inositol-requiring enzyme 1; XBP1: X-box binding protein 1) of the unfolded protein response; 24 and ultimately culminates into BAX (BCL2-associated X protein) and BAK1 (BCL2-antagonist/killer 1)-dependent mitochondrial apoptosis. 22, 23, 25 Hyp-PDT-induced ICD 8, 16, 17 consists of the concomitant preapoptotic emission (30 to 60 min post-PDT, before phosphatidylserine externalization) 9 , 17 of ATP and CALR through an overlapping molecular trail primarily governed by ROS production, the ER stressassociated kinase EIF2AK3, ER-to-Golgi anterograde transport and class I phosphoinositide-3-kinase (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha/PIK3CA) activity. 8, 9, 17 This is followed by late apoptotic (passive) release of chaperones like HSPA1A/HSP70 and HSP90AA1/HSP90. 9 Cancer cells undergoing Hyp-PDT-induced ICD cause efficient in vitro maturation of DCs (characterized by surface upregulation of CD86 and HLA-DR i.e. major histocompatibility complex, class II, maturation markers, amongst others), 9, 26 accompanied by production of IL1B in the absence of IL10 and induction of potent antitumor immunity, in vivo. 9 In terms of stimulation of the main antigen presenting cell of the innate immune system, i.e. DCs; 3, 7, 16 while cancer cell-associated macroautophagy (hereafter referred to as autophagy) is important for the attraction of DCs, 13 it has not been shown (to the best of our knowledge) how this affects the stimulation and maturation of DCs. Similarly, the knowledge on how cancer cell-associated autophagy modulates the clonal expansion or proliferation of T cells seldom exists. Rapid and extensive proliferation of T cells following encounter with 'danger' or antigenic stimulation (along with proper costimulation) 27 is one of the keystone functions of adaptive immunity. 28 This property is important for antitumor immunity 29 or tumor immunogenicity 30 such that inhibition of T cell proliferation causes tumoral immune resistance. 31 Interestingly, IFNG-production from T cells, which is crucial for the immunogenicity of cancer cells, 11, 13 has been shown recently to be strongly reduced when autophagy was ablated in cancer cells undergoing ICD. 13 Moreover, autophagy also plays an important role in optimal ATP release from cancer cells undergoing chemotherapy-induced ICD. 13, 32 We have previously observed that Hyp-PDT-mediated phox-ER stress 9, 22 in cancer cells causes accumulation of oxidatively damaged proteins (characterized by the presence of protein carbonyls) along with stimulation of the autophagic flux. 33, 34 Autophagy contributes to the clearance of these oxidatively damaged proteins, 33 thereby mitigating the damage caused by Hyp-PDT-induced ROS at the ER. 33, 34 This is interesting, considering that the surface mobilization of CALR, which is a ROS-dependent process, 9, 35 has been linked to the accumulation of damaged proteins. [35] [36] [37] [38] Since autophagy activated by Hyp-PDT counteracts the accumulation of oxidatively damaged proteins, 33 this raises the interesting possibility that autophagy may affect Hyp-PDT-induced ecto-CALR. Moreover, it has been proposed recently that autophagy might be crucial for Hyp-PDT-elicited ATP secretion as well, 16 an avenue that needs further attention. To this end, we wondered how autophagy in Hyp-PDT-treated cancer cells modulates various characteristics of ICD like emission of (active) immunogenic signals e.g. ecto-CALR and secreted ATP, maturation or stimulation of interacting DCs and stimulation or proliferation of CD4 + or CD8 + T cells.
In the present study we found that, in contrast to the expectations, Hyp-PDT-elicited ATP secretion was not regulated by autophagy. Similarly, the immune cells-based production of IL1B 
Results

Glutathione peroxidase-4 overexpression or L-histidine pretreatment reduces Hyp-PDT-induced CALR surface exposure and ATP secretion
Hyp-PDT was found to induce CALR surface exposure (ecto-CALR, exhibiting the characteristic "patchy" pattern of surface distribution) 10 ( Fig. S1A ) and ATP secretion (Fig. S1B) in the treated T24 cancer cells, as early as 1 h after PDT treatment, under plasma membrane non-permeabilizing conditions (Fig. S1C) , which is in line with our previous reports. 9, 10 Hyp-PDT-treated cancer cells secreted ATP in a dosedependent manner ( Fig. S1B and Fig. S2A ) and, in accordance with our earlier observations, 9 this process was paralleled by an increase in the intracellular ATP content in these early stages following Hyp-PDT treatment (Fig. S2B) . This early (1 h post-PDT), preapoptotic increase in intracellular ATP is probably a result of increased ER-mitochondria coupling 39 observed after Hyp-PDT. 9, 22 Moreover, we also detected late (24 h post-PDT) release of immunogenic signals like extracellular CALR, HSP90AA1 and HSPA1A in the conditioned media (Fig. S2C) . Curiously in this setup we did not observe, as strong a release of extracellular HMGB1, as observed for the aforementioned immunogenic signals (Fig. S2C) .
To understand the impact of the 'oxidative module' on emission of ecto-CALR and secreted ATP following Hyp-PDT we decided to investigate their emission in T24 cancer cells following L-histidine (LHist) pretreatment. L-histidine is a 1 O 2 quencher, which (as reported earlier by us) reduces the ROSdependent effects of Hyp-PDT. 9, 23 Cell surface biotinylation followed by immunoblot analysis of the isolated plasma membrane proteins following treatment with Hyp-PDT showed that indeed, as expected, pre-treatment with L-histidine reduced both ecto-CALR (Fig. 1A) and secreted ATP (Fig. 1B) in the treated cancer cells. To further substantiate these observations, we decided to investigate the emission of these immunogenic signals in HeLa human cancer cells overexpressing the antioxidant enzyme, glutathione peroxidase 4 (GPX4). GPX4 is a selenoenzyme that removes phospholipid hydroperoxides from cellular membranes, 40 which we have shown previously to confer protection from Hyp-PDT-induced apoptosis upon overexpression. 23, 34 This analysis revealed that following Hyp-PDT and also in the basal untreated conditions, cancer cells overexpressing GPX4 exhibited reduced levels of ecto-CALR as compared to their wild-type counterparts (Fig. 1C) . Similarly, GPX4 overexpression in cancer cells also reduced the overall ATP secretion following Hyp-PDT (Fig. 1D) . In order to rule out cancer cell type-tocell type and species-associated differences in the effects of GPX4 overexpression we repeated the above analysis in murine L929 cancer cells overexpressing GPX4. 34 In line with the results obtained in HeLa cells, overexpression of GPX4 in L929 cells also suppressed the induction of ecto-CALR (both in Hyp-PDT treated as well as basal conditions; Fig. 1E ) and secretion of ATP (Fig. 1F) . Interestingly, we observed that the levels of ATP secretion following Hyp-PDT treatment were cancer cell type-dependenta point that has been more systematically analyzed in the next section.
Taken together with our previous observations, 9, 22, 23 these results indicate that ROS signaling generated by Hyp-PDT contributes to CALR surface exposure and regulates ATP secretion by the cancer cells.
ATP secretion induced by Hyp-PDT is not autophagy-dependent
In our previous reports we had observed that Hyp-PDT-mediated activation of functional autophagy mitigates the oxidative damage caused by this treatment to proteins and organelles. 33, 34 Since, ecto-CALR and secreted ATP were a consequence of Hyp-PDT mediated oxidative stress, 9 we wondered whether autophagy might affect their emission. To investigate this, we knocked down ATG5 protein (ATG5 KD ) via RNA interference in two human cancer cell lines; the T24 human bladder cancer cells ( Fig. 2A) and the A375m human melanoma cells (Fig. 2B) . This approach resulted in approximately 60% silencing of this key proautophagic protein ( Fig. 2A and 2B ). In line with our previous reports, 33, 34 ATG5-competent cancer cells exhibited early (1 h post-PDT) activation of autophagy following Hyp-PDT; as revealed by progressive conversion of LC3-I into its cleaved and lipidated form LC3-II by western blot (Fig. S3A and S3B ) and the time-dependent accumulation of LC3-positive puncta, by immunofluorescence analysis (Fig.   S4 ). 41 Consistent with our previous studies, 33 partial suppression of ATG5 expression reduced autophagy stimulation following Hyp-PDT in cancer cells as revealed by decreased LC3-conversion and formation of LC3 puncta ( Fig. S3 and S4) . Moreover, as shown previously, 33 attenuation of autophagy by the partial reduction of ATG5 expression, also decreased the overall survival of the cancer cells after Hyp-PDT (thereby substantiating its prosurvival role during Hyp-PDT), 33 an effect that was more pronounced at milder Hyp-PDT doses (Fig. S5) .
Next, we analyzed the role of autophagy in ATP secretion following Hyp-PDT treatment.
Consistent with the previous studies published by us 9 as well as others, 42 this analysis revealed that the levels of ATP secretion are cancer cell type-dependent; indeed, at the same recovery time (1 h post-PDT)
and Hyp-PDT doses [equal doses as measured by survival- (Fig. S5) (Fig. 2C) . However, the similar levels of ATG5 KD obtained in both cell lines ( Fig. 2A and 2B ), did not significantly alter the corresponding levels of ATP secreted by these cancer cells following Hyp-PDT ( Fig. 2D and 2E ). This effect was not due to a residual ATG5 expression observed upon the siRNA/shRNA-based knockdown ( Fig. 2A and 2B) , since even the genetic deficiency of atg5 (in murine embryonic fibroblasts or MEFs i.e.
atg5
-/-MEFs), which renders these cells autophagy-incompetent, 33, 41 failed to alter the levels of ATP secreted following Hyp-PDT treatment (Fig. 2F) .
Thus, from the above observations we can conclude that, following Hyp-PDT autophagy is dispensable for optimal ATP secretion.
Ecto-CALR induced by Hyp-PDT correlates with the accumulation of oxidatively damaged proteins which is modulated by autophagy
We next analyzed the surface exposure of CALR following Hyp-PDT in autophagy-competent or autophagy-compromised (ATG5 KD ) cancer cells. Hyp-PDT induced rapid ecto-CALR in the autophagycompetent T24 and A375m cancer cells ( Fig. 3A and 3B) . Interestingly, ATG5 KD cancer cells exhibited a further increase in ecto-CALR induction following Hyp-PDT (Fig. 3A and 3B ). These observations reveal that autophagy has the ability to downregulate ecto-CALR levels following Hyp-PDT.
It has been reported that ecto-CALR induction tends to correlate or associate with processes that cause accumulation of damaged proteins. 9, 37, 38, [43] [44] [45] On the other hand, autophagy is a catabolic process that tends to remove damaged proteins like oxidized proteins and/or damaged organelles and reduce the effects of stress on a cell. 33, 41, 46 Since carbonylation of amino acid chains is a good indicator of the level of irreversible oxidative damage of proteins and since such proteins are marked for degradation/removal; 33, 47 we next investigated the pattern of early accumulation of carbonylated or oxidatively damaged proteins in cells responding to Hyp-PDT. Hyp-PDT treatment resulted in an early (1 h post-PDT) accumulation of carbonylated proteins in the T24 and A375m cancer cells ( Fig. 3C and 3D ). As anticipated based on former studies 41, 46 and our previous report, 33 knockdown of ATG5 resulted in an increased accumulation of carbonylated proteins in the cancer cells in response to both high ( Fig. 3C and 3D ) and medium ( In previous studies 33, 48 atg5 -/-MEFs were found to be protected from oxidative stress and to display a decreased accumulation of carbonylated/oxidized proteins as compared to their wild-type counterparts (Atg5 +/+ MEFs), 33 due to the upregulation of compensatory mechanisms (like chaperone-mediated autophagy) 33, 48 in these untreated MEFs. 33, 49 Indeed, early after Hyp-PDT (1 h) we observed that, while 
Autophagy attenuation in Hyp-PDT treated cancer cells increases phenotypic maturation of interacting DCs and IL6 production
Hyp-PDT induced ICD of cancer cells has been found to be associated with increased phenotypic and functional maturation of dendritic cells interacting with them. 9, 26 Increased maturation of DCs is one of the important prerequisites for ICD. 6, 7, 9 To this end, in view of the above results, we examined the impact of autophagy attenuation in Hyp-PDT treated cancer cells on the maturation of interacting DCs.
Autophagy Based on these interesting observations, we envisaged that it was crucial to gain further insights into the effect of blockage of cancer cell-associated autophagy on the functional status of these phenotypically mature DCs. To this end, we evaluated the conditioned media of A375m-DC cocultures for the pattern of certain important cytokines like IL1B (a proinflammatory cytokine, found to be important for ICD), 11 IL10 (a known immunosuppressive cytokine) 9, 50 and IL6 (an important proinflammatory cytokine). 43 On the one hand, in line with expectations, LPS strongly elicited the hu-iDCs to produce all of these three cytokines ( Fig. 4B-D , Table S1 ). The exposure of hu-iDCs to Hyp-PDT treated, autophagycompetent cancer cells did not induce production of any IL10 (Fig. 4B , Table S1 ) but led to production of considerable amounts of IL1B (Fig. 4C , Table S1 ) and IL6 ( Fig. 4D , Table S1 ). On the other hand, while the exposure of hu-iDCs to Hyp-PDT treated, autophagy-compromised (ATG5 KD ) cancer cells did not alter Table S1 ) and IL1B ( Fig. 4C , Table S1 ) production patterns observed in comparison to their autophagy-competent counterparts; yet this cancer cell-specific ablation of autophagy led to a comparatively higher production of IL6 cytokine (Fig. 4D, Table S1 ), not only in Hyp-PDT-treated conditions but interestingly also in the untreated conditions. Overall, this shows that following Hyp-PDT treatment and exposure to hu-iDCs, the autophagy-ablated cancer cells tend to create a relatively more proinflammatory cytokine pattern when compared to the autophagy-competent cancer cells.
Last, considering that autophagy attenuation in Hyp-PDT treated cancer cells increased ecto-CALR as well as phenotypic maturation of the interacting DCs; we wondered whether this increase in DC phenotypic maturation was attributable to the increase in ecto-CALR. To verify this conjecture, we decided to carry out hu-iDC phenotypic maturation analysis in the presence or absence of anti-CALR antibody; a strategy that we have previously utilized to reduce CALR-dependent phagocytosis of Hyp-PDT treated cancer cells. 10 To this end, we found that while autophagy attenuation in Hyp-PDT treated cancer cells increased the phenotypic maturation of hu-iDCs (Fig. 4E) as observed previously (Fig. 4A) yet antibodybased blocking of CALR failed to significantly reduce hu-iDC phenotypic maturation in response to both
Hyp-PDT treated autophagy-competent as well as autophagy-compromised cancer cells (Fig. 4E ). This suggests that the increase in DC phenotypic maturation observed following interaction with autophagycompromised cancer cells treated with Hyp-PDT is probably not ecto-CALR dependent.
Autophagy attenuation in Hyp-PDT treated cancer cells increases CD4 + or CD8 + T cell expansion in the presence of IFNG production
Beyond stimulation of the DCs, the subsequent stimulation of T cells is also crucial for antitumor immunity. 27, 29, 30 To this end, we decided to investigate the effect of autophagy-ablation in cancer cells undergoing Hyp-PDT elicited ICD on T-cell immunity. Autophagy-competent or autophagy-ablated A375m cancer cells were treated with Hyp-PDT and these were fed to the hu-iDCs for 24 h. Subsequently, these pulsed DCs were exposed to T cells followed by analysis of activation based on their increased proliferation. As compared to the untreated human cancer cells (CNTR), Hyp-PDT treated autophagy competent cancer cells induced statistically significant increase in proliferation of both human CD4 + ( Fig.   5A ) and human CD8 + T cells (Fig. 5B) , as indicated by the increased number of proliferating CD4 + /CD3 + and CD8 + /CD3 + double-positive T cells respectively (as measured by the eFluor®670 dye dilution). LPStreated hu-iDCs, as per expectations, induced strong increase in the proliferation of both CD4 + (Fig. 5A) and CD8 + T cells (Fig. 5B) . Remarkably however, autophagy-ablation (ATG5 KD ) in cancer cells in absence of any treatment, was on its own robust enough to cause a significant increase in the proliferation of both CD4 + and CD8 + T cells, to a degree that even exceeded that observed for Hyp-PDT treated autophagy competent cells (Fig. 5A and 5B) . Interestingly, Hyp-PDT treatment of these ATG5 KD cancer cells caused a further, statistically significant, increase in the proliferation of both CD4 + (Fig. 5A ) and CD8 + T cells (Fig. 5B) , when compared to the CD4 + /CD8 + T cell proliferations observed in response to untreated, ATG5 KD counterparts ( Fig. 5A and 5B). Thus, the combination of autophagy-ablation in cancer cells and Hyp-PDT treatment was still superior to autophagy-ablation alone in causing CD4 + or CD8 + T cell expansions ( Fig. 5A and 5B ). This clearly shows that autophagy attenuation in cancer cells (alone or in combination with Hyp-PDT treatment) instigates superior stimulation of T cells, leading to a significantly increased expansion of the CD4 + or CD8 + T cells. Overall these observations support a role for cancer cellassociated autophagy in suppressing robust T cell proliferation and expansion.
On the other hand, it is important to note that a mere increase in T cell expansion in the absence of the crucial antitumorigenic cytokine IFNG, may not sustain an antitumor effector function for these proliferating T cells. 51 The presence of IFNG has been associated with cytostatic/cytotoxic T cell function and antitumor effects like detection/elimination of tumor cells, robust antitumor effects instigated by ICD as well as enhancement of tumor cell immunogenicity. 52 To this end, we evaluated the conditioned media of A375m-DC-T cell cocultures for the production of IFNG. As expected, we observed that exposure of LPS-treated hu-iDC to naive T cells (i.e. purified CD3 + T cells) elicited the production of IFNG (Fig. 5C) . (Fig. 5C) . Although Hyp-PDT treated autophagy-ablated (ATG5 KD ) cancer cells did not increase IFNG production in these coculture settings to a significant level, they clearly did not repress IFNG production by T cells (Fig. 5C) . Intriguingly, this observation is in sharp contrast to the reported suppressive effect of autophagy on INFG production following chemotherapy-induced ICD. 13 In conclusion, these observations suggest a role for cancer cell-associated autophagy in suppressing efficient T cell immunity by decreasing the expansion of interacting CD4 + or CD8 + T cells that are producing IFNG to a certain extent following Hyp-PDT elicited ICD.
Discussion
In the current study, we found that autophagy induced in response to Hyp-PDT treatment in cancer cells Surface exposure of CALR during ICD depends upon an apical 'oxidative module' 8 such that
antioxidants have been shown to reduce it, 7, 35 an observation that we had previously extended to Hyp-PDT-induced ecto-CALR. 9 In this study, we further substantiate these reports by showing that overexpression of the antioxidant enzyme, GPX4, or pretreatment with 1 O 2 scavenger, L-histidine, also reduces Hyp-PDT induced ecto-CALR. On the other hand, the importance of the 'oxidative module' was still unresolved in the case of Hyp-PDT-induced ATP secretion. The observation of GPX4 overexpression or L-histidine pretreatment reducing ATP secretion following Hyp-PDT suggests that the 'oxidative module' is the most apical event able to modulate, at least in part, the emission of this immunogenic signal as well. Interestingly, we also observed that GPX4 overexpression reduced not only Hyp-PDT induced ecto-CALR but also basal ecto-CALR in untreated conditions. We have previously shown that on various levels 9, 10 an overlap (rather than independence) exists between the ecto-CALR trafficking pathways in basal, untreated conditions and ICD-inducing conditions. For instance, we had reported that, absence or ablation of EIF2AK3, PIK3CA and BAX and/or BAK1, reduced both basal as well as chemotherapy or
Hyp-PDT induced ecto-CALR. 9 To this end, the above observations about the effect of stable GPX4 overexpression on ecto-CALR imply that the 'oxidative module' might be another level on which the basal and Hyp-PDT-induced ecto-CALR trafficking pathways overlap. In case of basal, untreated conditions, variable amounts of intracellular ROS is generated due to the artificial in vitro cell culture conditions, 53 and this probably is responsible for the observed basal ecto-CALR induction.
Autophagy promotes survival following Hyp-PDT treatment (especially at mild PDT doses) by taking care of the damage (to proteins or organelles) caused by the oxidative stress exerted by this anticancer treatment modality. 33, 34 In view of our recent findings that Hyp-PDT was in fact capable of 13, 32 it was imperative to ascertain the impact of autophagy on the emission of ecto-CALR and secreted ATP after Hyp-PDT. However, contrary to the chemotherapy-induced ATP secretion, 13 we observed that Hyp-PDT-induced ATP secretion was independent of autophagy. On the other hand, interestingly, the presence of Hyp-PDT induced ecto-CALR varied depending on whether autophagy was attenuated or absent in a manner that correlated with the accumulation of oxidized/carbonylated proteins after Hyp-PDT. More specifically, while autophagy attenuation was found to increase both ecto-CALR and accumulation of oxidized/carbonylated proteins, yet autophagy deficiency (in atg5 -/-MEFs), which correlated with a decreased amount of oxidized proteins (probably due to the constitutive compensatory upregulation of chaperone-mediated autophagy) 33, 48 was found to decrease both.
Thus, in the context of a predominantly ROS-based anticancer treatment, like PDT, these observations indicate that autophagy might play a role in suppressing ecto-CALR, a major 'eat me' signal.
Whether there is a direct link between the mobilization of ecto-CALR from the ER and increased amount of oxidized proteins, at this subcellular site, is a matter that needs to be investigated in the near future. A direct link is plausible because accumulation of damaged or unfolded proteins has been known to overwhelm the retention system for chaperones like CALR thereby causing its 'escape' towards the surface. [36] [37] [38] 43 Moreover, this correlation is further supported by the observations that while blocking caspase signaling delays the execution of apoptosis 23 without altering ecto-CALR induction 9 following
Hyp-PDT-based phox-ER stress 22 yet, interference with autophagy (via ATG5-silencing) increases accumulation of oxidized proteins, 33 ecto-CALR and cell death, 33 likely by an amplification of ROSmediated ER stress (A. D. Garg and P. Agostinis, unpublished results). Last but not least, we recently found that Hyp-PDT induced an initial reticulophagy in the ER-photodamaged cells, which we revealed by the increase in the colocalization of CALR with the LC3-decorated autophagosomes. 31 Thus all together, these observations suggest that stimulation of autophagy after phox-ER stress interferes with the trafficking of CALR to the surface, by directly dampening the consequences of phox-ER stress.
Interestingly, autophagy attenuation in Hyp-PDT-treated cancer cells increased the phenotypic maturation of interacting DCs. Moreover comparison of the cytokine profiles produced by the interaction of DCs with autophagy-ablated cancer cells and the autophagy-competent cancer cells hinted at a small overall shift towards a more proinflammatory profile (i.e., a significantly increased IL6 production) when cancer cell-associated autophagy is ablated. Overall, this means that autophagy stimulated in ROSdamaged cancer cells might play an important role in suppressing the stimulation of DCs. Of note, we observed that the increased ecto-CALR caused by autophagy attenuation was not responsible for the improved DC maturation, since CALR-blocking antibodies 10 failed to reduce it. This raises the attractive possibility that autophagy regulates (within the Hyp-PDT treated cancer cells) the "emission" of other unknown DC maturation-inducing factors. Here, HMGB1 3 and its recently found association with autophagy-based secretion (induced by epidermal growth factor receptor-targeted diphtheria toxin), 55 makes it a possible candidate. However, the fact that HMGB1 is susceptible to ROS-based inactivation [56] [57] [58] and that we did not detect a significant HMGB1 release from Hyp-PDT treated cancer cells in conditions where the release of other immune-modulatory molecules like HSPs was strongly detected, 9 makes HMGB1 an unlikely candidate in this ICD paradigm.
DCs can provide the proper stimulatory and costimulatory signals required for the activation of naive T cells. 27 Such activation leads to increased expansion or proliferation of CD4 + or CD8 + T cells 29 accompanied by IFNG production, 27 processes that have been found to be important for antitumor immunity, ICD and tumor immunogenicity. 11, 13, 29, 30 Interestingly it was recently reported that in the case of chemotherapy-induced ICD, blockage of autophagy can cause ablation of CD4 + or CD8 + T cell immunity. 13 In case of Hyp-PDT induced ICD instead, autophagy attenuation in cancer cells caused superior stimulation of T cells, leading to a significantly increased expansion of the CD4 + or CD8 + T cells.
Moreover, mitigation of autophagy in cancer cells did not hamper the production of IFNG. This observation is in direct contrast to previous observations where autophagy-ablation was shown to decrease IFNG production in response to cancer cells treated with chemotherapeutic ICD inducers. 13 These observations further substantiate the possibility that in cancer cells treated with Hyp-PDT, autophagy might be suppressing the emission or presence of as-yet-unknown factors that ultimately help in mediating processes that are crucial for the efficacy of antitumor immunity. This creates a vital need to characterize in the near future, the identity of these antitumor immunity promoting factors that are suppressed by cancer cell-associated autophagy. 59 Moreover, in another recent study, the ablation of hypoxia-induced autophagy in cancer cells was reported to result in accentuation of cytotoxic T cell responses thereby meaning that hypoxiainduced autophagy can help evade T cells-based immunity. 60 Overall our observations along with the reported ones imply a role for cancer cell-associated autophagy in general evasion from cancer immunosurvelliance and antitumor immunity; a conjecture that needs to be thoroughly investigated and confirmed in future studies.
In conclusion, this study shows that in cancer cells treated with Hyp-PDT, ATP secretion is partly ROS-dependent but autophagy-independent while ecto-CALR induction is downregulated by autophagy (Fig. 5D) . We had shown previously that after Hyp-PDT treatment of cancer cells, ecto-CALR and secreted ATP follow overlapping molecular pathways to reach the extracellular space. 9, 10, 17 The observations made in this study imply that this overlapping molecular trail detaches on the level of autophagy. Moreover, we found that cancer cell-associated autophagy after Hyp-PDT suppresses the maturation of the interacting DCs, IL6 production and proliferation of CD4 + or CD8 + T cells (Fig. 5D) . Considering that ecto-CALR, maturation of interacting DCs and stimulation of T cells are important determinants of ICD in cancer cells; 6, 7, 9 our study suggests that cancer cell-associated autophagy in the case of Hyp-PDT treatment might be helping in evasion from molecular and immunological determinants of ICD.
Materials and Methods
Reagents
Hypericin was prepared, purified and stored as described previously. 9, 23 Antibody against LC3
(microtubule-associated protein light-chain 3) and HSP90AA1 were purchased from Cell Signaling Technology (3868 and 4874, respectively). Anti-calreticulin antibody was purchased from Stressgen (SPA-600), unless mentioned otherwise. Anti-FAS (N-18, M-20 and C-20) and anti-HSPA1A antibodies were purchased from Santa Cruz Biotech (sc-714, sc-716, sc-715, and sc-33575, respectively). Anti-ACTB/β-actin antibody and L-histidine were purchased from Sigma (A5316 and 53319, respectively). Anti-ATG5
and anti-HMGB1 antibodies were purchased from Abcam (ab109490 and ab65003). Secondary antibodies conjugated to horseradish peroxidase were purchased from Cell Signaling Technology (7076 and 7074).
Cell lines, LDH assay, MTS assay and induction of immunogenic cell death
HeLa, T24 and MEF cells were cultured at 37°C under 5% CO 2 Scientific; L-004374-00-0005) to culture dishes with 2 mL serum-free culture media (final concentration of 40 nM siRNA). 3 h following transfection, 2.5 mL culture media containing 5% FBS was added.
Experiments were carried out 48 h after transfection.
Analysis of human dendritic cell (DC) maturation and cytokines
Human immature dendritic cells (hu-iDC) were isolated and cultured as described previously 61 followed by DC maturation analysis as described previously. 9 Briefly, respective A375m cells exposed to higher Hyp- 
Analysis of T cell proliferation and IFNG production
The hu-iDCs were isolated and cultured as described above. Thereafter, the respective A375m cells exposed to higher Hyp-PDT treatment (and recovered at 24 h post-PDT) were coincubated with hu-iDCs at a ratio of 1:1 for 24 h (in 96 well U-bottomed plates). Hu-iDCs stimulated with 100 ng/ml of Escherichia coli-derived lipopolysaccharide (LPS) for 24 h (Sigma, L3012) were used as positive controls.
Simultaneously, purified CD3 + T-cells were prepared from peripheral blood mononuclear cells The conditioned coculture media derived from these DC/A375m/T cell coincubation experiments were collected and checked for immunoreactive levels of human IFNG measured using the human IFNG FlowCytomix Simplex kit (eBioscience, BMS8228FF). The samples were prepared according to the manufacturer's instructions and analyzed on a Gallios TM flow cytometer (Beckman Coulter, A94299) and the FlowCytomix TM software (eBioscience) was used for data analysis.
ATP assays
Following Hyp-PDT treatments, extracellular ATP was measured in the conditioned (serum-free) media and intracellular ATP was determined after saponin-based lysis via an ATP assay mix (Sigma, FLAAM-1VL) based on luciferin-luciferase conversion, following the manufacturer's instructions. Bioluminescence was assessed by optical top reading via a FlexStation 3 microplate reader (Molecular Devices Inc., 0310-5627, Sunnyvale, California, USA).
Protein carbonylation detection assay
The detection of protein carbonyl derivates was carried out as described previously. 62 Briefly, the cells were either treated with Hyp-PDT or left untreated, followed by preparation of cell lysates. Thereafter, 50 
Biotinylation of cell surface proteins
Biotinylation of cell surface proteins was performed as described in our previous studies. 9, 10 Time points used for this analysis were confirmed to be associated with non-significant plasma membrane permeabilization via LDH release assay as described previously. 9, 10 For control samples (i.e. untreated cells), one set of samples were exposed to the buffer containing biotin (denoted by '+BIO') while the other set was exposed to only the buffer as a negative control (denoted by '-BIO'). The capture of plasma membrane proteins was confirmed by detecting FAS in the biotinylated protein fractions. In all the figures (as applicable), 'Plasma membrane proteins' are proteins in the biotinylated surface fraction while 'intracellular proteins' are the unbound proteins that are non-biotinylated.
Immunoblotting
Preparation of cell lysates, determination of protein concentration and immunoblotting was done as described. 63 Wherever applicable, the bands of proteins on the blots were quantified through the ImageJ software for determination of the relative integrated band density.
Fluorescence detection of cell surface CALR and intracellular LC3
1 h following Hyp-PDT treatment, T24 cells (on a glass slide) were incubated with 1 µM Sytox Green (1:200) (Cell Signaling Technology, 3868) (at room temperature for 1 h). This was followed by washing, incubation with the anti-rabbit IgG antibody conjugated with Alexa fluor 488 (1:400) (Invitrogen, A-11008) and counterstaining with DAPI (1 µg/ml for 10 min) (Invitrogen, D1306). Thereafter the respective samples were mounted using the Prolong Gold antifade reagent (Invitrogen, P36930). Confocal fluorescence images of these samples were obtained using a Nikon A1R confocal unit mounted on a Ti2000 inverted microscope controlled by NIS elements acquisition software (Nikon Instruments Inc., Melville, NY, USA).
Statistical analysis
Data are presented either in fold changes, absolute reading units or in percentages with mean ± s. 
